You are not currently logged in.
Access JSTOR through your library or other institution:
Frequent Hepatitis C Virus Superinfection in Injection Drug Users
Belinda L. Herring, Kimberly Page-Shafer, Leslie H. Tobler and Eric L. Delwart
The Journal of Infectious Diseases
Vol. 190, No. 8 (Oct. 15, 2004), pp. 1396-1403
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30078061
Page Count: 8
You can always find the topics here!Topics: Superinfection, Hepacivirus, Genotypes, Infections, Polymerase chain reaction, Phylogenetics, Viremia, Injections, Viral load, RNA
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
The frequency of hepatitis C virus (HCV) superinfection with a divergent viral strain was determined in a cohort of recently infected young injection drug users (IDUs) with an HCV incidence rate of 25%. HCV was amplified, by use of polymerase chain reaction (PCR), from plasma samples collected from 25 HCV-infected individuals over an average period of 12 months, and their viral sequences were compared. Phylogenetic analysis identified 5 IDUs with superinfection (20%) occurring after seroconversion: 2 IDUs were superinfected with different HCV genotypes, and 3 were superinfected with divergent strains of the same genotype. The superinfecting strains were not detected as minority variants (<0.5%) in the initial plasma HCV quasi species. Extensive measures were taken to exclude PCR contamination and mix-up of samples, and superinfection results were concordant at 2 HCV genetic loci. HCV superinfection in IDUs, both intra- and intergenotype, is therefore a frequent event, with an incidence rate similar to that of de novo infections. These results suggest that no cross-protecting immunity develops during the first year of chronic infection with HCV.
The Journal of Infectious Diseases © 2004 Oxford University Press